Investor Relations
Driving value through innovation and strategic growth.
Tandem Scientific is at the forefront of magnetic bead technology, addressing a critical need in the rapidly expanding life sciences market. Our proprietary Zero Sedimentation technology offers unmatched performance for automation and high-throughput screening, positioning us as a key partner for major diagnostic and pharmaceutical companies.
- FY 2024 Annual Report
Released: March 15, 2025 Download PDF - Q3 2024 Quarterly Results
Released: October 20, 2024 Download PDF
We are committed to the highest standards of corporate governance and ethical business practices. Our board of directors brings together experienced leaders from the biotechnology, finance, and technology sectors.
For stock information and investor inquiries, please contact our Investor Relations team.
Email: investors@tandemscientific.com
Phone: +82-2-123-4567